{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:13:50Z","timestamp":1778652830720,"version":"3.51.4"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pneumocystis jirovecii pneumonia (PJP) remains a life-threatening opportunistic infection in renal transplant recipients despite universal prophylaxis, with its risk factors in this setting poorly defined. This study aimed to investigate these factors and develop a nomogram to predict PJP risk, identifying patients requiring extended prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Demographic characteristics and perioperative outcomes of consecutive patients who underwent kidney transplantation from DCD or DCBD donors at a high-volume kidney transplant center in China between January 2016 and January 2019 were retrospectively analyzed. A nomogram was developed using data from a retrospective training cohort based on a Cox regression model. The model was tested in a validation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 702 patients, 52 developed postoperative PJP (7.4%). PJP occurred in 38 of 491 patients (7.73%) in the training cohort and in 14 of 211 patients (6.64%) in the validation cohort. The nomogram included the following variables: postoperative CD4+T cell count, CD8\/lymphocyte ratio (CD8\/L), blood glucose, NEU percentage and CRP \u2265 8\u03bcg\/mL. The C-statistics and AUC values of the nomogram for PJP prediction were 0.88, 0.93, and 0.89 in the training, validation, and entire cohorts, respectively. The incidence of PJP was significantly higher in the high-risk group than in the low-risk group across all three cohorts (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Renal transplant recipients with lower CD4+T cell counts and higher CD8\/L, blood glucose, NEU percentage, and CRP levels are at increased risk of PJP. The nomogram may serve as a useful and practical tool for predicting the individualized risk of PJP after kidney transplantation, facilitating the identification of high-risk patients requiring extended prophylaxis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1778937","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:52:36Z","timestamp":1778651556000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk prediction of pneumocystis jirovecii pneumonia in kidney transplant recipients using a clinical nomogram"],"prefix":"10.3389","volume":"16","author":[{"given":"Qu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Organ Transplantation, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]},{"name":"Faculty of Hepatopancreatobiliary Surgery, The First Medical Center of Chinese People\u2019s Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghui","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory Department, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiao","family":"Song","sequence":"additional","affiliation":[{"name":"Oncology Clinical Development, Johnson & Johnson (J&J) Innovative Medicine Research & Development","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanlan","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory Department, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Third Medical Center of Chinese People's Liberation Army (PLA) General Hospital","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2024-327710","article-title":"Complications of paediatric kidney transplantation: a paediatrician\u2019s review","author":"Alessa","year":"2025","journal-title":"Arch. Dis. Child"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.103842","article-title":"HIV and AIDS-defining opportunistic illnesses in the state of Qatar: a cohort population-based retrospective study covering 17 years, (2000-2016)","volume":"78","author":"Ali","year":"2022","journal-title":"Ann. Med. Surg. (Lond)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.2147\/idr.S372427","article-title":"Supplementary role of immunological indicators in the diagnosis and prognosis of pneumocystis pneumonia in non-HIV immunocompromised patients","volume":"15","author":"Cao","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1186\/s12879-025-11821-6","article-title":"Daily single-strength vs. thrice-weekly double-strength trimethoprim\/sulfamethoxazole for pneumocystis jirovecii prophylaxis in kidney transplant recipients: a non-inferiority randomized control trial","volume":"25","author":"Chantapoh","year":"2025","journal-title":"BMC Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.12659\/aot.918195","article-title":"Impact of increased duration of trimethoprim-sulfamethoxazole prophylaxis for pneumocystis pneumonia after renal transplant","volume":"24","author":"Chapman","year":"2019","journal-title":"Ann. Transplant."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00125-0","article-title":"T-cell subsets in pneumocystis pneumonia","volume":"14","author":"Chen","year":"2025","journal-title":"Clin. Trans. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof9010023","article-title":"Risk of pneumocystis jirovecii pneumonia among solid organ transplant recipients: a population-based study","volume":"9","author":"Cheng","year":"2022","journal-title":"J. Fungi (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15320","article-title":"Risk factors for pneumocystis jirovecii pneumonia after kidney transplantation: a systematic review and meta-analysis","volume":"38","author":"Cheng","year":"2024","journal-title":"Clin. Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12890-022-02041-8","article-title":"Prognostic implication of bronchoalveolar lavage fluid analysis in patients with pneumocystis jirovecii pneumonia without human immunodeficiency virus infection","volume":"22","author":"Chung","year":"2022","journal-title":"BMC Pulm. Med."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00178","article-title":"CD4(+) T-cell-independent secondary immune responses to pneumocystis pneumonia","volume":"7","author":"De la Rua","year":"2016","journal-title":"Immunology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14175936","article-title":"A 30-year epidemiological study of opportunistic fungal infections in people living with HIV in Greece: associations with demographic characteristics and immune status","volume":"14","author":"Douvali","year":"2025","journal-title":"J. Clin. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1093\/ndt\/gfq689","article-title":"Risk factors for pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients","volume":"26","author":"Eitner","year":"2011","journal-title":"Nephrol. Dial Transplant."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.2147\/ijgm.S349786","article-title":"Nomograms for death from pneumocystis jirovecii pneumonia in HIV-uninfected and HIV-infected patients","volume":"15","author":"Feng","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman","year":"2019","journal-title":"Clin. Transplant."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13877","article-title":"CD4(+) T cell lymphopenia predicts mortality from pneumocystis pneumonia in kidney transplant patients","volume":"34","author":"Freiwald","year":"2020","journal-title":"Clin. Transplant."},{"key":"B16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/nep.12054","article-title":"Pneumocystis jirovecii colonization among renal transplant recipients","volume":"18","author":"Fritzsche","year":"2013","journal-title":"Nephrol. (Carlton)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1504380","article-title":"Pneumocystis jirovecii pneumonia increases the 3-months mortality of anti-MDA5-antibody-positive dermatomyositis patients","volume":"15","author":"Gao","year":"2024","journal-title":"Front. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12882-018-1142-8","article-title":"Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes","volume":"19","author":"Garg","year":"2018","journal-title":"BMC Nephrol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1399-3062.2011.00691.x","article-title":"Pneumocystis jirovecii pneumonia in kidney transplantation","volume":"13","author":"Goto","year":"2011","journal-title":"Transpl Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/cid\/ciy682","article-title":"A multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients","volume":"68","author":"Hosseini-Moghaddam","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/ajt.12947","article-title":"Risk factors of pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis","volume":"15","author":"Iriart","year":"2015","journal-title":"Am. J. Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1456","DOI":"10.1093\/cid\/ciaa1611","article-title":"Identification of predictive markers and outcomes of late-onset pneumocystis jirovecii pneumonia in kidney transplant recipients","volume":"73","author":"Kaminski","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4093\/dmj.2025.0508","article-title":"Diabetes mellitus and infectious diseases: current evidence and clinical implications","volume":"49","author":"Kim","year":"2025","journal-title":"Diabetes Metab. J."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2025.100972","article-title":"Late-onset pneumocystis pneumonia after kidney transplantation: a systematic review and meta-analysis of prevalence, risk factors, and outcomes","volume":"40","author":"Konwai","year":"2026","journal-title":"Transplant. Rev. (Orlando Fla.)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/s41598-017-01818-w","article-title":"Risk factors for pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"10682","DOI":"10.1038\/s41598-022-14580-5","article-title":"Comparison of early and late pneumocystis jirovecii pneumonia in kidney transplant patients: the Korean Organ Transplantation Registry (KOTRY) study","volume":"12","author":"Lee","year":"2022","journal-title":"Sci. Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1128\/jcm.03494-14","article-title":"Cellular profiles of bronchoalveolar lavage fluid and their prognostic significance for non-HIV-infected patients with pneumocystis jirovecii pneumonia","volume":"53","author":"Lee","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3109\/00365548.2014.936492","article-title":"Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population","volume":"46","author":"Leth","year":"2014","journal-title":"Scand. J. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jinf.2020.04.001","article-title":"The profile of peripheral blood lymphocyte subsets and serum cytokines in children with 2019 novel coronavirus pneumonia","volume":"81","author":"Li","year":"2020","journal-title":"J. Infect."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s11739-023-03353-1","article-title":"A machine learning diagnostic model for pneumocystis jirovecii pneumonia in patients with severe pneumonia","volume":"18","author":"Li","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1177\/0300060517715339","article-title":"Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome","volume":"45","author":"Li","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4631297","article-title":"Pneumocystis jirovecii pneumonia in patients with nephrotic syndrome: application of lymphocyte subset analysis in predicting clinical outcomes","volume":"2020","author":"Liu","year":"2020","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12651","article-title":"The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: a systematic review","volume":"19","author":"Messiaen","year":"2017","journal-title":"Transpl Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ajic.2015.11.012","article-title":"Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: risk factors and implications for infection control","volume":"44","author":"Mulpuru","year":"2016","journal-title":"Am. J. Infect. Control"},{"key":"B35","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/TP.0b013e3181aad256","article-title":"Analysis of USRDS: incidence and risk factors for pneumocystis jiroveci pneumonia","volume":"88","author":"Neff","year":"2009","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00134-024-07547-9","article-title":"Severe pneumocystis jirovecii pneumonia: time to reassess our practices","volume":"50","author":"Nseir","year":"2024","journal-title":"Intensive Care Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s12072-023-10612-y","article-title":"Nomograms should be noted","volume":"18","author":"Obi","year":"2024","journal-title":"Hepatol. Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"611","DOI":"10.4049\/jimmunol.1500112","article-title":"B lymphocytes are required during the early priming of CD4+ T cells for clearance of pneumocystis infection in mice","volume":"195","author":"Opata","year":"2015","journal-title":"J. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1097\/tp.0000000000003576","article-title":"A comprehensive evaluation of risk factors for pneumocystis jirovecii pneumonia in adult solid organ transplant recipients: a systematic review and meta-analysis","volume":"105","author":"Permpalung","year":"2021","journal-title":"Transplantation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/qco.0000000000001002","article-title":"Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention","volume":"37","author":"Saadatzadeh","year":"2024","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.trim.2013.05.003","article-title":"Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for pneumocystis jirovecii pneumonia in kidney transplant recipients","volume":"28","author":"Sch\u00fcrmann","year":"2013","journal-title":"Transplant. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1186\/s12879-024-09757-4","article-title":"Prognostic analysis of concurrent pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus: a retrospective study","volume":"24","author":"Shi","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2353\/ajpath.2006.050724","article-title":"CD8 T cells modulate CD4 T-cell and eosinophil-mediated pulmonary pathology in pneumocystis pneumonia in B-cell-deficient mice","volume":"168","author":"Swain","year":"2006","journal-title":"Am. J. Pathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00436-018-6131-0","article-title":"Prevalence and genotyping of pneumocystis jirovecii in renal transplant recipients-preliminary report","volume":"118","author":"Szyd\u0142owicz","year":"2019","journal-title":"Parasitol. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1086\/526778","article-title":"Early predictors of mortality from pneumocystis jirovecii pneumonia in HIV-infected patients: 1985-2006","volume":"46","author":"Walzer","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12890-025-03700-2","article-title":"A nomogram-based clinical prediction model for adverse clinical outcomes in non-HIV pneumocystis jirovecii pneumonia patients","volume":"25","author":"Wang","year":"2025","journal-title":"BMC Pulm. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s11255-025-04696-8","article-title":"Impact of different immunosuppressants on the incidence of pneumocystis jirovecii pneumonia in kidney transplant recipients: a systematic review and meta-analysis","volume":"58","author":"Wang","year":"2026","journal-title":"Int. Urol. Nephrol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15021","article-title":"Risk factors and outcomes of pneumocystis pneumonia in solid organ transplant recipients: impact of posttransplant lymphoproliferative disorder","volume":"37","author":"Yetmar","year":"2023","journal-title":"Clin. Transplant."},{"key":"B50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12072-024-10754-7","article-title":"Development of nomograms to predict outcomes for large hepatocellular carcinoma after liver resection","volume":"19","author":"Zeng","year":"2025","journal-title":"Hepatol. Int."},{"key":"B51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/cas.16392","article-title":"A population-based study using nomograms to predict overall and cancer-specific survival in HPV-associated CSCC","volume":"116","author":"Zheng","year":"2025","journal-title":"Cancer Sci."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13688","article-title":"Clinical characteristics and risk factors for late-onset pneumocystis jirovecii pneumonia in kidney transplantation recipients","volume":"67","author":"Zhu","year":"2024","journal-title":"Mycoses"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.860644","article-title":"Clinical manifestations and outcomes of renal transplantation patients with pneumocystis jirovecii pneumonia and cytomegalovirus co-infection","volume":"9","author":"Zou","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101593","article-title":"Single-center retrospective analysis of pneumocystis jirovecii pneumonia in patients after deceased donor renal transplantation","volume":"72","author":"Zou","year":"2022","journal-title":"Transpl Immunol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1778937\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:52:37Z","timestamp":1778651557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1778937\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":54,"alternative-id":["10.3389\/fcimb.2026.1778937"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1778937","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1778937"}}